Autologous Tissue for Breast Augmentation/Reconstruction

About Etienna Bio

Etienna Bio, founded in 2021 and based in Cambridge, USA, is developing a regenerative aesthetic platform to create autologous tissue for procedures like breast augmentation and facial rejuvenation. Its core technology, licensed from the University of Massachusetts, can expand a patient's stem cells over 1,000-fold and differentiate them into adipocytes or fibroblasts. The company is led by a team with extensive regulatory and clinical experience, positioning it to address a significant market opportunity by offering a permanent, natural alternative to current synthetic solutions.

Therapeutic Areas